A nomogram integrating DCE-MRI imaging features and clinicopathological parameters for predicting pathological complete response in HER2-positive breast cancer - Top-Institutions - MDSpire

A nomogram integrating DCE-MRI imaging features and clinicopathological parameters for predicting pathological complete response in HER2-positive breast cancer

  • By

  • Jianlong Wu

  • Bo Gao

  • Jingna Wu

  • Zhongsheng Peng

  • Min Ye

  • Changyou Zhong

  • Mengxia Zhuang

  • Jinfeng Zhang

  • June 24, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Meizhou People’s Hospital
    Meizhou People’s Hospital

    Meizhou, Guangdong

    Key Differentiators

    • Oncology

  • #2

    Yale University School of Medicine
    Yale University School of Medicine

    New Haven, Connecticut

    Key Differentiators

    • Oncology

  • #3

    Institut Jules Bordet
    Institut Jules Bordet

    Brussels, Brussels-Capital Region

    Key Differentiators

    • Oncology

  • #4

    Université Libre de Bruxelles
    Université Libre de Bruxelles

    Brussels, Brussels-Capital Region

    Key Differentiators

    • Oncology

  • #5

    University Hospital Dresden
    University Hospital Dresden

    Dresden, Saxony

    Key Differentiators

    • Oncology

Original Source(s)

A nomogram integrating DCE-MRI imaging features and clinicopathological parameters for predicting pathological complete response in HER2-positive breast cancer

  • by Jianlong Wu, Bo Gao, Jingna Wu, Zhongsheng Peng, Min Ye, Changyou Zhong, Mengxia Zhuang, Jinfeng Zhang

  • June 24, 2026

Related Content

Radiomics-based interpretable machine learning model from multiphasic CT imaging for predicting pathological grade in upper tract urothelial carcinoma: a multicenter study

MRI characteristics of cervical radioiodine-avid lymph nodes detected on post-therapeutic ¹³¹I whole-body scintigraphy in differentiated thyroid carcinoma

Endocrine-driven inflammatory–epigenetic adaptation as a proposed axis of radioresistance in endocrine-exposed prostate cancer: a translational hypothesis